When Mg2+ was added to rat oncomodulin, a parvalbumin-like tumour protein, changes in the c.d. spectrum and tyrosine fluorescence intensity were observed. The addition of Ca2+ resulted in even greater changes in these spectra. The fluorescence excitation spectra of apo-and Mg-oncomodulin were superimposable, whereas that of Ca-oncomodulin was markedly different. The u.v.-absorption spectrum of the Ca2+ form also showed major differences from those of the other two forms. These observations indicate that Ca2+ induced a significant and specific conformational change in the protein that was not observed on binding Mg2+. In contrast, the conformational change induced by either Mg2+ or Ca2+ was identical in the homologous rat parvalbumin. This Ca2+-specific conformational change may be the basis for oncomodulin's Ca2+-dependent protein/protein interaction.
The superfamily of bivalent-cation-binding proteins includes calmodulin, troponin C and the parvalbumins (Barker et al., 1979; Kretsinger, 1980) . Oncomodulin is a protein originally isolated from rat hepatomas (MacManus, 1979 (MacManus, ,1980 Criss & Kakiuchi, 1982) . It is also present in other rodent and human tumours MacManus & Whitfield, 1983) . The amino acid sequence of rat oncomodulin showed it to be homologous to the parvalbumins, but a comparison with rat muscle parvalbumin indicated the tumour protein to be more like a ,B-parvalbumin than a muscle a-parvalbumin (MacManus et al., 1983a,b) . Besides the primary structural similarities to the Ca2+-binding superfamily, oncomodulin also exhibited calmodulin-like properties by its ability to stimulate some calmodulin-dependent enzymes (MacManus, 1981; MacManus & Whitfield, 1983 ). In addition, oncomodulin also mimicked calmodulin in stimulating DNA synthesis in Ca2+-deprived cells . None of these properties was shared by rat parvalbumin.
The root of the manner in which calmodulin functions as a modulator is the change in conformation it undergoes when Ca2+ binds (Klee & Vanaman, 1982) . This conformational change brings a hydrophobic area to the surface, which allows protein-protein interaction (LaPorte et al., 1980; Tanaka & Hidaka, 1980; Klee & Vanaman, 1982) . Although parvalbumins also undergo conformational change, the change is neither Ca2+- Vol. 220 specific nor adequate for the parvalbumins to function as modulators (Demaille, 1982; Wnuk et al., 1982) .
The primary structures of calmodulin, troponin C and parvalbumin contain no information to explain their differential modulator action. The explanation has been presumed to lie in the tertiary structures of these proteins (Demaille, 1982; Klee & Vanaman, 1982) . Likewise there is nothing in the primary structure of rat oncomodulin or of rat parvalbumin to explain the differential ability of the tumour protein to mimic some calmodulin actions (MacManus et al., 1983a,b) . Therefore a study of the conformational changes in rat oncomodulin induced by the binding of metal ions was undertaken, and these were compared with similar changes in rat parvalbumin.
Materials and methods
Rat oncomodulin was purified from Morris hepatoma 5123tc (MacManus, 1980) , and rat parvalbumin from skeletal muscle, by using as a basis the procedure . Both proteins were shown to be homogeneous by amino acid analysis (MacManus et al. 1983a,b) .
The proteins were stripped of metals by precipitation with trichloroacetic acid (Haiech et al., 1981) . The apo-oncomodulin had a residual metal content of 0.18mol of Ca/mol of protein, and no detectable Mg, and the apo-parvalbumin had 0.15 mol of Ca and 0.11 mol of Mg/mol of protein, when measured by atomic absorption spectroscopy on a Pye-Unicam SP. 191 instrument. The oncomodulin precipitated with acid was fully renaturable to the native state, since there was no difference in the various spectra of the renatured or untreated proteins.
All buffers were passed through a column of Chelex 100 cation-exchange resin (Bio-Rad Laboratories, Mississauga, Ont., Canada) before use. This treatment decreased the contamination to 3 !M-Ca2+ and 1 pM-Mg2+ .
The stock metal salt solutions were made from ultrapure salts (Alfa Division, Ventron Corp., Danvers, MA, U.S.A.). The stock magnesium salt was 0.5M-magnesium acetate in the appropriate buffer and had a 12 pM-Ca2+ contamination. The stock calcium salt solution was 0.5M-CaCO3 (solubilized with HCl; Aristar BDH Chemicals, Toronto, Ont., Canada) in the appropriate buffer, and had a 40 sM-Mg2+ contamination. When diluted during use, these cross-contaminations were below the 1-3 uM background metal-ion contaminations in the buffers used. Samples were always handled in plasticware.
U.v.-absorption spectra were measured on a Cary 219 spectrophotometer. U.v. difference spectra were obtained by adding equal volumes of a solution of 400 M-apo-oncomodulin in 150mM-KCl/0.25mM-Hepes [4-(2-hydroxyethyl)-1-piperazine-ethanesulphonic acid] buffer, pH7.2, to cuvettes in the reference and sample beams. After the baseline was balanced, small portions of solutions of the metal ions were added to the sample cuvette and equal volumes of buffer were added to the reference cuvette, and the spectra were recorded.
The c.d. spectra were taken on a calibrated (Gillen & Williams, 1975) (Provencher & Glockner, 1981; Provencher, 1982a,b) Cd. spectroscopy in the 250-300nm region Since oncomodulin contains no tryptophan and only one cysteine residue per molecule, the c.d. spectrum in the 250-300nm region may be assigned to phenylalanine and tyrosine. A multiband set assignable to the oncomodulin phenylalanine chromophores was present, and was composed of bands centred at 268-262nm, with a shoulder at 253nm (Fig. 2b) . A broad band due to tyrosine was centred at 280nm. This oncomodulin spectrum was very similar to the c.d. spectrum of calmodulin (Klee & Vanaman, 1982) . Mg2+addi-tion caused intensity changes in the bands attributed to phenylalanine, but no change in the intensity of the tyrosine band was recorded. Ca2+ addition intensified the spectrum in the phenylalanine region. In contrast with Mg-oncomodulin, the tyrosine region of Ca-oncomodulin exhibited a major loss of c.d. intensity, suggesting either the involvement of tyrosine in forming a complex with Ca2+ or a strong perturbation of the tyrosine residue on Ca2+ binding.
The binding of Mg2+ or Ca2+ to rat parvalbumin also caused an increase in intensity, but only in the phenylalanine region (Fig. 3b) , since this parvalbumin is devoid of tyrosine (Berchtold et al., 1982; MacManus et al., 1983b) . With this parvalbumin, both Mg2+ and Ca2+ produced the same intensity change in apo-parvalbumin, with no Ca2+-specific alteration visible as with oncomodulin.
C.d. spectroscopy in the 190-250nm region
Oncomodulin had a two-band c.d. spectrum indicative of helical content (Fig. 2a) . Addition of Mg2+ caused an increase in the band intensities, with a further increase caused by Ca2+. The same spectrum was obtained whether the Ca2+ was added to apo-oncomodulin or to Mg-oncomodulin.
In contrast, both the Mg2+-and Ca2+-saturated forms of parvalbumin had equal increases in intensity. Mg2+ caused only a partial conversion of the apo-oncomodulin into its Ca2+-saturated form (Fig. 2a) , whereas it caused full conversion in the case of parvalbumin (Fig. 3a) . Mg-oncomodulin also had an altered ratio of the band intensities at 208 and 222nm ([0] When the intensity of the 222nm band of oncomodulin was titrated against increasing bivalent-cation concentrations, the major fraction of the conformational change appeared to saturate at either approx. 2Ca2+/molecule or 1 Mg2+/molecule (Fig. 4) . Evidence of a second, perhaps nonspecific, site was seen with Mg2+/oncomodulin ratios greater than 1 :1. Full saturation of the effect only occurred at metal-ion/protein ratios above 10:1 (Fig. 4) . The parvalbumin titration, on the other hand, was monophasic for both metal ions, and gave the appearance of being fully saturated at metal ion/protein ratios of approx. 2:1 (results not shown).
Approximations of secondary structure of these metal-ion-binding proteins were made by using the c.d. spectra in the 190-205nm region and the CONTIN program (Provencher, 1982a,b) . Given the qualitative nature of such estimates, the results suggested that the two apoproteins have approxi- mately the same amount of ct-helix, an amount that is in agreement with the parvalbumin helical content estimated by other methods (Cox et al., 1979; Berchtold et al., 1982) . The two rat proteins appeared to have different amounts of fl-turn, and random structure (Table 1) (Fig. 3) .
caused increases in helical content, and concomi- Apo-oncomodulin over the apo form or 8% over the Mg2+ form (Table   2 ).
Comparison of the fluorescence of apo-oncomodulin with that of tyrosine (both spectra normalized at their maxima) indicated an additional contribution to the fluorescence of the apo-protein \ at longer wavelengths (Fig. 5) . Making the assumption that the fluorescence at 301 nm was n solely attributable to tyrosine, the two spectra were ; normalized at 301 nm, and a difference spectrum 50 was produced (Fig. 5 inset) by subtracting the 310 3 370 tyrosine spectrum from the apo-oncomodulin Wavelength (nm) spectrum. The maximum of this difference spectrum, centred at 345 nm, was indicative of a tyrosinate contribution to the fluorescence. Similar o spectra were obtained for Mg-or Ca-oncomodulin Apo-oncomodulin (Fig. 5 inset) but showed a decrease-in the / / tyrosinate content.
Tyrosine
The quantum yields of the oncomodulin derivatives were measured by integration of the spectra and using tyrosine as a standard [quantum yield = 0.14 (Chen, 1967) fluorescence maximum intensity, the fractional fluorescence, so that while the tyrosine fluorescence was increasing on metal ion bonding (Table  2 ) the tyrosinate fluorescence was decreased (Fig. 5  inset) .
The corrected fluorescence excitation spectra of the apo-and metal-ion-bound oncomodulin were most revealing. These spectra were determined by using an emission wavelength of 310nm (Fig. 6) . When the excitation spectra were normalized to have the same intensity at their identical maxima (276nm), the excitation spectra of the apo-and Mg-oncomodulin were superimposable (Fig. 6) . However, the spectrum of Ca-oncomodulin was significantly different from those of both apo-and Mg-oncomodulin. This spectrum of Ca-oncomodu- lin had an increased intensity on the high-energy side of the maximum (272nm), and a different shape. This was indicative of an increase in the energy-transfer efficiency of phenylalanine to tyrosine in the Ca2+ form.
Discussion
The troponin C superfamily of bivalent-cationbinding proteins includes the four-Ca2+-site calmodulin, the two-Ca2+ -site + two-Ca2+ /Mg2+ -site troponin C and the two-Ca2+/Mg2+-site parvalbumins (Barker et al., 1979; Kretsinger, 1980; Klee & Vanaman, 1982; Demaille, 1982; Potter & Johnson, 1982; Wnuk et al., 1982) . The same conformational change was caused by binding Ca2+ or Mg2+ in parvalbumins, when monitored by either fluorescence or c.d. spectroscopy (Cox et al., 1979; Moeschler et al., 1980) . This was also found with rat parvalbumin (Figs. 3a and 3b) , although some subtle differences have been described in other parvalbumins during investigations with proton n.m.r. or microcalorimetry (Birdsall et al., 1979; Moeschler et al., 1980) . On the other hand, in oncomodulin Ca2+ produces an easily discernible specific change over and above that induced by Mg2 . This was observed with u.v.-absorption spectroscopy (Fig. 1) , with c.d. spectroscopy (Figs.  2a and 2b ) or with either emission or excitation fluorescence spectroscopy (Table 2 and Fig. 6 ). This Ca2+-specific conformational change was observed by Ca2+ addition to either apo-oncomodulin or Mg-oncomodulin.
The structural estimates from the c.d. data show that Ca2+ induces in oncomodulin an increase in ahelical content over and above that induced by Mg2+ (Table 1 ). In addition, Mg-oncomodulin would seem to have less random structure than Caoncomodulin, possibly owing to the smaller Mg2+ ion collapsing the binding domain further than Ca2 , leading to a tighter structure. This has been previously suggested from n.m.r. studies on carp parvalbumin (Birdsall et al., 1979) .
Comparison of the primary structures of the putative CD and EF binding domains of rat oncomodulin and parvalbumin are shown in Fig.  7 . The observed fluorescence can be assigned to that of the two tyrosine residues in oncomodulin, Tyr-57 and Tyr-65. Both these tyrosine residues are in the CD loop, Tyr-57 as a binding ligand (carbonyl group) and Tyr-65 in the flanking helix (Kretsinger, 1980) . The Tyr-57 is homologous to the Tyr-99 of the vertebrate calmodulins (Klee & Vanaman, 1982) . The large (2-3-fold) increase in calmodulin fluorescence on Ca2+ binding has been attributed in the main to Tyr-1 38 (Klee & Vanaman, 1982) . This is supported by the relatively small increase (40%) in the fluorescence of oncomodulin, 
Comparison of amino acid sequences in the putative metal-ion binding domains (Moews & Kretsinger, 1975) of rat oncomodulin (MacManus et al., 1983a) and rat parvalbumin (Berchtold et al., 1982; MacManus et al., 1983b) The boxes indicate identity in both proteins and the one-letter amino acid code is used (IUPAC-IUB Commission on Biochemical Nomenclature). X, Y, Z, -X, -Y and -Z refer to the metal ion binding ligands (Kretsinger, 1980) . which can be considered to have only the Tyr-99 of calmodulin.
The formation of tyrosinate from the excited state of tyrosine is a fluorescence-quenching mechanism (Rayner et al., 1978) . The tyrosinate fluorescence in Fig. 5 can only result from proton removal from an excited tyrosine residue by proximate acid residues such as aspartic acid or glutamic acid. Such residues surround Tyr-57, and are suitable ligands for metal-ion binding (Fig. 7) . Therefore the increase in fluorescence intensity on cation binding may occur because these acid residues are no longer available for proton abstraction. However, Tyr-65 may also be involved through interaction with acid residues in other parts of the protein.
The interpretation of the fluorescence excitation spectra involved the Tyr-65 residue. The excitation spectra of apo-oncomodulin and Mg-oncomodulin were superimposable (Fig. 6) . The structure in this spectrum observed at wavelengths shorter than the maxima indicated some energy transfer from phenylalanine to tyrosine in these forms. On binding Ca2+ there was a change in the highenergy region of the Ca-oncomodulin excitation spectrum compared with the normalized apooncomodulin spectrum (Fig. 6 ). There was an increase in the structure and intensity, which indicated an increase in the energy-transfer efficiency from one or more phenylalanine residues to the tyrosine residues. A model of oncomodulin built on parvalbumin co-ordinates (Moews & Kretsinger, 1975) indicated that Phe-49, or less probably Phe-47, may be well positioned to transfer energy to Tyr-65. On the basis of this model there is no phenylalanine residue with the correct orientation to allow energy transfer to Tyr-57. Thus we concluded that Ca2+ induced a specific conformational change that was primarily located in the CD loop.
The differences observed in the excitation spectra of apo-and Ca-oncomodulin assist in the interpretation of the u.v. difference spectra (Fig.  1) . The fluorescence excitation spectra indicated that there must be changes in the orientation and/or the interaction between phenylalanine and tyrosine residues on binding Ca2+. This change in orientation and interaction between residues presumably results in increased electronic interaction between these residues, which is the reason for the observed u.v. difference spectrum on binding a2+. Ca2C
omparison of the primary structures of the two binding domains of rat oncomodulin and rat parvalbumin gives no hint as to why this Ca2+-specific conformational change occurs (Fig. 7) . Indeed, comparison of the sequences of calmodulin, troponin C and parvalbumin do not give any indication of why some sites are Ca2+-specific whereas others bind either Ca2+ or Mg2+ (Kretsinger, 1980; Klee & Vanaman, 1982; Demaille, 1982; Potter & Johnson, 1982; Wnuk et al., 1982) . Changes in the tertiary structure induced by metalion binding has been invoked as the source of the specific conformational change, which allows the regulatory protein-protein interaction (LaPorte et al., 1980; Tanaka & Hidaka, 1980; Klee & Vanaman, 1982) .
Muscle parvalbumins, which lack large Ca2+-specific conformational changes (Figs. 3a and 3b) ; Cox et al., 1979; Moeschler et al., 1980) are described as being incapable of protein-protein interaction (Demaille, 1982; Wnuk et al., 1982) . Although like a parvalbumin in primary structure (MacManus et al., 1983a,b) , oncomodulin has been demonstrated to be capable of such interaction, shown by Ca2+-specific binding of hepatoma proteins to imobilized oncomodulin (MacManus & Whitfield, 1983) , by stimulation of some calmodulin-dependent enzymes (MacManus, 1981) or by stimulation of DNA synthesis in Ca2+-deprived cells . Thus oncomodulin has calmodulin-like activity and parvalbumin-like primary structure.
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The stoichiometry of the metal-ion association suggests that rat parvalbumin binds either 2 Ca2+ ions or 2 Mg2+ ions per molecule, in agreement with the work of many (Demaille, 1982; Wnuk et al., 1982) . On the other hand, oncomodulin binds 2 Ca2+ ions or 1 Mg2+ ion per molecule (Fig. 4) (Fig. 7) , and so it is concluded this is a Ca2+/Mg2+-binding site for oncomodulin, as well as for parvalbumin. The CD loop would therefore be the Ca2+-specific site, a conclusion that is supported by the changes observed in the c.d. spectrum (Fig. 2) , the Ca2+-specific tyrosine fluorescence change (Table 2 ) and the phenylalanine-to-tyrosine energy transfer (Fig.  6 ). Thus oncomodulin, instead of being analogous to calmodulin, is more akin to troponin C. Indeed, the tumour protein may be more akin again to cardiac troponin C, which has only one Ca2+_ specific site in addition to the two Ca2+/Mg2+-binding sites (Potter & Johnson, 1982) . The description of oncomodulin as a 'mini-cardiactroponin C' would narrow its regulatory ability compared with calmodulin (Klee & Vanaman, 1982; Potter & Johnson, 1982) and would also reconcile the inability of oncomodulin to stimulate all calmodulin-dependent enzymes (MacManus & Whitfield, 1983) .
